{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T02:47:24Z","timestamp":1772160444900,"version":"3.50.1"},"reference-count":47,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2009,10,5]],"date-time":"2009-10-05T00:00:00Z","timestamp":1254700800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2010,1]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>\n                    Gain\u2010of\u2010function mutations of kit tyrosine kinase receptor are associated with mastocytosis. Two subclones of the HMC1 mast leukaemia cell line were used; both express an identical\n                    <jats:italic>KIT<\/jats:italic>\n                    allele\u2010specific regulatory type mutation (V560G), but differ in that one also expresses an enzymatic site type mutation (D816V) that confers on them resistance to imatinib mesylate tyrosine kinase inhibitor. In both cell lines, proliferation was suppressed and apoptosis induced by the combination of\n                    <jats:italic>KIT<\/jats:italic>\n                    gene silencing and \u03b1\u2010tocopherol succinate (\u03b1\u2010TOS), a derivate of \u03b1\u2010tocopherol, also known as vitamin E. Furthermore, HMC1 cells with decreased kit levels by\n                    <jats:italic>KIT<\/jats:italic>\n                    silencing, failed to form tumours when xenotransplanted into immunocompromised mice and the animals were treated systemically with \u03b1\u2010TOS. Targeting kit in the presence of \u03b1\u2010TOS represents a new approach against proliferation of human mast leukaemia cell lines.\n                  <\/jats:p>","DOI":"10.1111\/j.1365-2141.2009.07918.x","type":"journal-article","created":{"date-parts":[[2009,10,5]],"date-time":"2009-10-05T09:26:19Z","timestamp":1254734779000},"page":"59-68","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Combination of\n                    <i>KIT<\/i>\n                    gene silencing and tocopherol succinate may offer improved therapeutic approaches for human mastocytosis"],"prefix":"10.1111","volume":"148","author":[{"given":"Irene","family":"Ruano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Gargini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Izquierdo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,12,14]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-472X(03)00112-7"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428199909058472"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1535-6108(02)00122-8"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/0145-2126(88)90050-1"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd839"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/362849a0"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6600683"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1044-579X(03)00040-3"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-002-0575-z"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-04-015545"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-006-9228-0"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.06.060"},{"key":"e_1_2_6_14_1","first-page":"769","article-title":"Coexpression of the c\u2010kit and stem cell factor genes in breast carcinomas","volume":"6","author":"Hines S.J.","year":"1995","journal-title":"Cell Growth and Differentiation"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.279.5350.577"},{"key":"e_1_2_6_16_1","first-page":"3049","article-title":"Coexpression of c\u2010kit receptor and the stem cell factor receptor in gynecological tumors","volume":"54","author":"Inoue M.","year":"1994","journal-title":"Cancer Research"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/17.21.6124"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21640"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M410800200"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrg2006"},{"key":"e_1_2_6_21_1","first-page":"370","article-title":"Autocrine growth of small cell lung cancer mediated by co\u2010expression of c\u2010kit ans stem cell factor","volume":"56","author":"Krystal G.W.","year":"1996","journal-title":"Cancer Research"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10495-006-0620-9"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(01)00028-5"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.1999.00488.x"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.222406899"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-05-0070"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M403319200"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1014378901843"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.106.030122"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdm223"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2007.06619.x"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-0541"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1080\/01635589409514349"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22187"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm1207"},{"key":"e_1_2_6_36_1","first-page":"3637","article-title":"The histone deacetylase inhibitor MS\u2010275 promotes differentiation or apoptosis in human leukemia cells through a process regulated by generation of reactive oxygen species and induction of p21CIP1\/WAF1 1","volume":"63","author":"Rosato R.R.","year":"2003","journal-title":"Cancer Research"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20020972"},{"key":"e_1_2_6_38_1","first-page":"339","article-title":"Selective RNAi\u2010mediated inhibition of mutated c\u2010kit","volume":"5","author":"Ruano I.","year":"2009","journal-title":"Journal of RNAi and Gene Silencing"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1006988832729"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6601707"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2006.02.054"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4401549"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190400010775"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.11187"},{"key":"e_1_2_6_45_1","first-page":"863","article-title":"Vitamin E succinate is a potent novel antineoplastic agent with high selectivity and cooperativity with tumor necrosis factor\u2010related apoptosis\u2010inducing ligand (Apo2 ligand) in vivo","volume":"8","author":"Weber T.","year":"2002","journal-title":"Clinical Cancer Research"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-002-0435-5"},{"key":"e_1_2_6_47_1","first-page":"953","article-title":"Vitamin E succinate (VES) induces Fas sensitivity in human breast cancer cells: role for Mr 43,000 Fas in VES\u2010triggered apoptosis","volume":"59","author":"Yu W.","year":"1999","journal-title":"Cancer Research"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1206120"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2009.07918.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2009.07918.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T19:24:10Z","timestamp":1697397850000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2009.07918.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,14]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["10.1111\/j.1365-2141.2009.07918.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2009.07918.x","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1166980.629085","asserted-by":"object"}]},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,14]]},"assertion":[{"value":"2009-12-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}